Skip to main content
Clinical Trials/CTRI/2023/04/051443
CTRI/2023/04/051443
Not yet recruiting
Phase 2

A Comparative clinical study to evaluate the efficacy of Triphaladya Guggulu along with or without Panchkol Phant in the management of Agnimandhya w.s.r. to hypothyroidism..

Self0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E039- Hypothyroidism, unspecified
Sponsor
Self
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Self

Eligibility Criteria

Inclusion Criteria

  • diagnosed cases of hypothyroidism on the basis of serum TSH, T3,T4 levels\- TSH level \>4\.2 to 8 uIu/ml, T3 and T4 level \- normal or less than normal value. patients having clinical features of hypothyroidism \-puffiness of the face and eyelids, peripheral oedema, dry coarse skin, breathlessness, constipation, weakness, lethargy, fatigue, muscle ache, menstrual abnormality, hair loss

Exclusion Criteria

  • patient with renal disease, post myocardial infarction, congestive heart failure, pregnant women, patient with acute medical illness, patient with concomitant inflammatory disease, patient with hypothalamic\- pituitary disorder, malignancy, patient on drug phenytoin, carbamazepine, sertraline, furosemide and non steroidal anti inflammatory drugs. patient on treatment of lipid lowering drugs or 3 months prior history of talking lipid lowering drugs.

Outcomes

Primary Outcomes

Not specified

Similar Trials